Comparative Pharmacology
Head-to-head clinical analysis: PRALIDOXIME CHLORIDE AUTOINJECTOR versus SODIUM NITRITE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: PRALIDOXIME CHLORIDE AUTOINJECTOR versus SODIUM NITRITE.
PRALIDOXIME CHLORIDE (AUTOINJECTOR) vs SODIUM NITRITE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Reactivates acetylcholinesterase inhibited by organophosphate poisoning by binding to the organophosphate moiety.
Sodium nitrite is a vasodilator that acts by relaxing vascular smooth muscle, primarily through the generation of nitric oxide (NO). It also converts hemoglobin to methemoglobin, which binds cyanide, thereby acting as an antidote for cyanide poisoning.
1-2 g IV or IM, repeat after 1 hour if muscle fasciculations persist, then every 6-12 hours as needed. Administer as a 5% solution (1g in 20mL) over 5-10 minutes IV; IM into deltoid or anterolateral thigh.
300 mg (10 mL of a 30 mg/mL solution) intravenously over 2-4 minutes, followed immediately by sodium thiosulfate. May repeat once after 30-60 minutes if needed.
None Documented
None Documented
Terminal elimination half-life is approximately 1.2-2.5 hours in adults with normal renal function. In organophosphate poisoning, prolonged half-life may occur due to redistribution or renal impairment; clinical context: requires repeated dosing or continuous infusion to maintain therapeutic concentrations.
Terminal half-life: 0.5–1 hour (nitrite); due to rapid oxidation to nitrate, which has a half-life of 5–8 hours. Clinically, methemoglobin reduction requires monitoring for 2–4 hours.
Primarily renal excretion of unchanged drug and metabolites; approximately 80-90% of a dose is excreted in urine within 4-6 hours, with 50% as unchanged pralidoxime and the remainder as metabolites (e.g., 1-methyl-2-pyridone-2-aldoxime). Minor biliary/fecal elimination (<10%).
Primarily renal; 60-70% as nitrate and unchanged nitrite; minor biliary (<5%) and fecal (<2%) elimination.
Category C
Category C
Antidote
Antidote